Shen Chong, Li Zhi, Zhang Yinglang, Zhang Zhe, Wu Zhouliang, Da La, Yang Shaobo, Wang Zejin, Zhang Yu, Qie Yunkai, Zhao Gangjian, Lin Yuda, Huang Shiwang, Zhou Mingli, Hu Hailong
Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Front Oncol. 2022 Oct 10;12:1018285. doi: 10.3389/fonc.2022.1018285. eCollection 2022.
Increasing evidences have demonstrated that circular RNA (circRNAs) plays a an essential regulatory role in initiation, progression and immunotherapy resistance of various cancers. However, circRNAs have rarely been studied in bladder cancer (BCa). The purpose of this research is to explore new circRNAs and their potential mechanisms in BCa. A novel ceRNA-regulated network, including 87 differentially expressed circRNAs (DE-circRNAs), 126 DE-miRNAs, and 217 DE-mRNAs was constructed to better understanding the biological processes using Cytoscape 3.7.1 based on our previously high-throughput circRNA sequencing and five GEO datasets. Subsequently, five randomly selected circRNAs (upregulated circ_0001681; downregulated circ_0000643, circ_0001798, circ_0006117 and circ_0067900) in 20 pairs of BCa and paracancerous tissues were confirmed using qRT-PCR. Functional analysis results determined that 772 GO functions and 32 KEGG pathways were enriched in the ceRNA network. Ten genes (PFKFB4, EDNRA, GSN, GAS1, PAPPA, DTL, TGFBI, PRSS8, RGS1 and TCF4) were selected for signature construction among the ceRNA network. The Human Protein Atlas (HPA) expression of these genes were consistent with the above sequencing data. Notably, the model was validated in multiple external datasets (GSE13507, GSE31684, GSE48075, IMvigor210 and GSE32894). The immune-infiltration was evaluated by 7 published algorithms (i.e., TIMER, CIBERSORT, CIBERSORT-ABS, QUANTISEQ, MCPCOUNTER, XCELL and EPIC). Next, Correlations between riskscore or risk groups and clinicopathological data, overall survival, recognized immunoregulatory cells or common chemotherapeutic agents of BCa patients were performed using wilcox rank test, chi-square test, cox regression and spearman's correlation analysis; and, these results are significant. According to R package "GSVA" and "clusterProfiler", the most significantly enriched HALLMARK and KEGG pathway was separately the 'Epithelial Mesenchymal Transition' and 'Ecm Receptor Interaction' in the high- vs. low-risk group. Additionally, the functional experiments also revealed that the overexpression of has_circ_0067900 significantly impaired the proliferation, migration, and invasion capacities of BCa cells. Collectively, the results of the current study provide a novel landscape of circRNA-associated ceRNA-regulated network in BCa. The ceRNA-associated gene model which was constructed presented a high predictive performance for the prognosis, immunotherapeutic responsiveness, and chemotherapeutic sensitivity of BCa. And, has_circ_0067900 was originally proposed as tumor suppressor for patients with BCa.
越来越多的证据表明,环状RNA(circRNAs)在各种癌症的发生、发展和免疫治疗耐药性中起着至关重要的调节作用。然而,circRNAs在膀胱癌(BCa)中的研究很少。本研究的目的是探索BCa中新型circRNAs及其潜在机制。基于我们之前的高通量circRNA测序和五个GEO数据集,使用Cytoscape 3.7.1构建了一个新的ceRNA调控网络,包括87个差异表达的circRNAs(DE-circRNAs)、126个DE-miRNAs和217个DE-mRNAs,以更好地理解生物学过程。随后,使用qRT-PCR在20对BCa和癌旁组织中验证了随机选择的5个circRNAs(上调的circ_0001681;下调的circ_0000643、circ_0001798、circ_0006117和circ_0067900)。功能分析结果确定ceRNA网络中富集了772个GO功能和32条KEGG通路。在ceRNA网络中选择了10个基因(PFKFB4、EDNRA、GSN、GAS1、PAPPA、DTL、TGFBI、PRSS8、RGS1和TCF4)进行特征构建。这些基因的人类蛋白质图谱(HPA)表达与上述测序数据一致。值得注意的是,该模型在多个外部数据集(GSE13507、GSE31684、GSE48075、IMvigor210和GSE32894)中得到了验证。通过7种已发表的算法(即TIMER、CIBERSORT、CIBERSORT-ABS、QUANTISEQ、MCPCOUNTER、XCELL和EPIC)评估免疫浸润。接下来,使用wilcox秩和检验、卡方检验、cox回归和spearman相关分析对BCa患者的风险评分或风险组与临床病理数据、总生存期、公认的免疫调节细胞或常用化疗药物之间的相关性进行分析;并且,这些结果具有显著性。根据R包“GSVA”和“clusterProfiler”,高风险组与低风险组中最显著富集的HALLMARK和KEGG通路分别是“上皮-间质转化”和“细胞外基质受体相互作用”。此外,功能实验还表明,has_circ_0067900的过表达显著损害了BCa细胞的增殖、迁移和侵袭能力。总的来说,本研究结果提供了BCa中circRNA相关ceRNA调控网络的新图景。构建的ceRNA相关基因模型对BCa的预后、免疫治疗反应性和化疗敏感性具有较高的预测性能。并且,最初提出has_circ_0067900作为BCa患者的肿瘤抑制因子。